These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 911461)

  • 21. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R; Campbell C; Wellinghoff W; Gelb L
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HBsAg/IgM complexes in serum of HBsAg carriers: partial characterization and clinical significance.
    Rizzi R; Almi P; Touscoz G; Canese MG; Toti M; Palla M; Bonino F
    Boll Ist Sieroter Milan; 1983 May; 62(2):137-44. PubMed ID: 6626320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
    Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayiannis A; Sjogren MH; Engle R; Karpodini E; Purcell RH
    Hepatogastroenterology; 1986 Aug; 33(4):151-4. PubMed ID: 3758906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B surface antigen and immunoglobulin M complexes in chronic carriers and patients with acute and chronic liver diseases.
    Ayoola EA; Olubuyide I
    Afr J Med Med Sci; 1989 Mar; 18(1):21-4. PubMed ID: 2545079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical and epidemiological significance of serum PreS1/anti-PreS1 in HBV infection.
    Mi Z; Feng F; Zhang X; Lian Z; Wang H; Tong Y
    Chin Med J (Engl); 1999 Apr; 112(4):321-4. PubMed ID: 11593530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical importance of assessment of HBsAg/IgM complexes in chronic hepatitis B.
    Stránský J; Vodák M; Zichová M
    Acta Virol; 1993; 37(2-3):170-4. PubMed ID: 8105661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection and significance of anti-pre S2 in patients with hepatitis B and HBsAg carriers].
    Ding Z
    Zhonghua Yi Xue Za Zhi; 1990 Nov; 70(11):611-4, 42. PubMed ID: 1963350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence of anti-delta antibodies in HBsAg carriers].
    Söyletir G; Babacan F; Göral M; Can A
    Mikrobiyol Bul; 1989 Apr; 23(2):97-101. PubMed ID: 2626106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The prognostic significance of quantitative HBsAG determination in acute hepatitis B].
    Joller-Jemelka HI; Pfister HF; Grob PJ
    Schweiz Med Wochenschr; 1985 Sep; 115(37):1249-56. PubMed ID: 3903984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E antigen in the serum of HBs antigen-positive patients on maintenance dialysis and after transplantation.
    Albert FW; Brisam A; Traut G; Thamer G
    Proc Eur Dial Transplant Assoc; 1978; 15():306-11. PubMed ID: 368777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlations between the detection of e antigen or antibody and electron microscopic pattern of hepatitis B surface antigen (HBsAg) associated particles in the serum of HBsAg carriers.
    Trepo C; Bird RG; Zuckerman AJ
    J Clin Pathol; 1977 Mar; 30(3):216-20. PubMed ID: 403201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.
    Hopf U; Meyer zum Büschenfelde KH; Arnold W
    N Engl J Med; 1976 Mar; 294(11):578-82. PubMed ID: 1107836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HBsAg immune complexes in the course of infection with hepatitis B virus.
    Madaliński K; Bragiel I
    Clin Exp Immunol; 1979 Jun; 36(3):371-8. PubMed ID: 487641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytogenic analysis in HBsAg positive subjects, healthy carriers and patients with acute-phase hepatitis].
    Vianello MG; Fasce LC; Mura MS; Andreoni G; Scalise G
    Boll Ist Sieroter Milan; 1979 Jul; 58(3):266-72. PubMed ID: 518760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The "e" antigen system in HBs antigen carriers (author's transl)].
    Schnell P; Courouce AM; Opolon P; Darnis F
    Nouv Presse Med; 1978 Oct; 7(35):3105-8. PubMed ID: 103075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The nature and incidence of cryoproteins in hepatitis B antigen (HbsAg) positive patients.
    Mcintosh RM; Koss MN; Gocke KJ
    Q J Med; 1976 Jan; 45(177):23-38. PubMed ID: 130650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular and humoral immunity in viral hepatitis.
    Lee WM
    Am J Clin Pathol; 1976 May; 65(5 Suppl):866-9. PubMed ID: 85410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Specific circulating immune complexes in patients with hepatitis B].
    Chang ML; Chou CT; Chao YC; Lee CF; Chang DM; Hsu K
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 May; 20(2):119-26. PubMed ID: 3652780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.